Elevance Health (ELV)

The sleeper story is ELV planning to shed billions in Medicaid revenue via market exits over 12-18 months, fundamentally reshaping their government portfolio while everyone debates temporary margin pressures. The Street sees 'beat and raise' but half the beat was ACA seasonality that reverses in H2 and they're using one-time gains to fund transformation because the core business can't. The binding constraint isn't rates or even utilization, it's that their medical management capabilities aren't keeping pace with behavioral health and specialty pharmacy explosion, forcing geographic retreat rather than operational improvement. Most revealing quote: 'We expect to exit additional Medicaid markets over the next 12-18 months.' My view changes if Medicaid utilization actually bends in H2 or if AI investments show measurable medical cost savings.